Pfizer Inc. today announced positive topline results from the final prespecified overall survival (OS) analysis of the TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase ...
Some results have been hidden because they may be inaccessible to you